Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

10. Segment and Geographic Information (Details - Geographic regions) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Sales revenue from geographical territories	$ 4,647,000	$ 3,174,000	$ 12,394,000	$ 8,158,000
Increase (decrease) in sales revenue	$ 1,473,000		$ 4,236,000
Percent change in sales revenue	46.00%		52.00%
Sales Revenue, Segment [Member] \| United States [Member]
Sales revenue from geographical territories	$ 2,883,000	1,671,000	$ 7,010,000	4,741,000
Increase (decrease) in sales revenue	$ 1,212,000		$ 2,269,000
Percent change in sales revenue	73.00%		48.00%
Sales Revenue, Segment [Member] \| Latin America [Member]
Sales revenue from geographical territories	$ 772,000	465,000	$ 2,095,000	465,000
Increase (decrease) in sales revenue	$ 307,000		$ 1,630,000
Percent change in sales revenue	66.00%		351.00%
Sales Revenue, Segment [Member] \| Europe and Other [Member]
Sales revenue from geographical territories	$ 992,000	$ 1,038,000	$ 3,289,000	$ 2,952,000
Increase (decrease) in sales revenue	$ (46,000)		$ 337,000
Percent change in sales revenue	(4.00%)		11.00%